Firstly, the CT26 tumor-bearing mice were divided into six groups and intratumorally injected with PBS, the CpG-C negative control GC, and four doses of HP06T07 (0.3, 1, 2.5, and 5 mg/kg) in the right flank on day 8, 11, 14, 17, and 20 (Figure 4A). The gene discussed is DDX53; the disease is neoplasm.